Results of a phase III, double-blind, placebo-controlled trial of megestrol acetate modulation of P-glycoprotein-mediated drug resistance in the first-line management of small-cell lung carcinoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 • 3,039 citations
Expression of a multidrug-resistance gene in human tumors and tissues.
1987 • 1,547 citations
Expression of Multidrug Resistance Gene in Human Cancers
1989 • 1,305 citations
Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.
1990 • 1,063 citations
The multidrug transporter, a double-edged sword.
1988 • 763 citations
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
1987 • 343 citations
Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
1990 • 320 citations
A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer
1990 • 238 citations
Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line
1987 • 205 citations
Function and Regulation of the Human Multidrug Resistance Gene
1992 • 186 citations
MDR1 Gene Expression in Lung Cancer
1989 • 182 citations
Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line.
1990 • 157 citations
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study
1995 • 155 citations
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.
1996 • 141 citations
Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial
1994 • 120 citations
Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein
1989 • 107 citations
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial.
1994 • 101 citations
High-dose megestrol acetate. A possible treatment for cachexia.
1987 • 100 citations
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study
1993 • 88 citations
Characterization of an etoposide-resistant human small-cell lung cancer cell line
1990 • 68 citations
A randomised clinical study of verapamil in addition to combination chemotherapy in small cell lung cancer
1993 • 66 citations
Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein
1992 • 61 citations
Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
1988 • 53 citations
Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69
1989 • 52 citations
Multidrug Resistance in the Laboratory and Clinic
1994 • 52 citations
High-dose megestrol acetate. A possible treatment for cachexia
1987 • 24 citations
MDR1 gene expression in lung cancer
1990 • 8 citations
Approaches to the analysis of quality of life data: Experiences gained from a medical research council lung cancer working party palliative chemotherapy trial
1995 • 7 citations
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group study
1996 • 6 citations
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study
1994 • 4 citations
Cited By (0)
No citing papers found in database